H. Radtke et al., GUIDELINES REQUIRED BY LAW FOR THE MANAGE MENT OF COMPLAINTS OF SIDE-EFFECTS OF BLOOD COMPONENTS, Infusionstherapie und Transfusionsmedizin, 22(3), 1995, pp. 186-195
Objective: To prevent dangers to health resulting from the application
of drugs, the legislator requires the central registration and evalua
tion of all drug risks, especially of side effects and reciprocal effe
cts. Since 1988 pharmaceutical enterprises have had to denominate a qu
alified person ('Stufenplanbeauftragter') who is responsible for the f
ulfilment of obligatory reporting. In case of complaints or side effec
ts he has to take suitable measures according to a special plan ('Stuf
enplan'). Data Sources: The basis of this survey are the legal require
ments for drugs ('Arzneimittelgesetz') and supplementary regulations w
hich define the duties of the 'Stufenplanbeauftragter' Results: Blood
components are subject to the legal requirements ('Arzneimittelgesetz'
) without reservations. Therefore the corresponding regulations have t
o be applied without modification in institutes for transfusion medici
ne. In this article the tasks of the 'Stufenplanbeauftragter' are summ
arized and practical experience of a university institute for transfus
ion medicine is presented. Conclusions: In connection with the transmi
ssion of viral infectious diseases it became evident that the 'Stufenp
lanbeauftragter' is very important for the initiation of effective mea
sures in case of serious side effects. The security of blood component
s could be improved by the realization of the corresponding legal requ
irements in the institutes for transfusion medicine.